ResMed Corp. v. Cleveland Medical Devices, Inc.

IPR2025-00158

ResMed Corp. successfully convinced the PTAB to institute IPR proceedings against Cleveland Medical Devices, Inc.'s patent (No. 11690512). The Board found that ResMed demonstrated a reasonable likelihood of prevailing on Ground 1, allowing the challenge to proceed despite neutral merits.

Jurisdiction
US PTAB
Case Number
IPR2025-00158
Judge(s)
SHERIDAN K. SNEDDEN, NEIL T. POWELL, CYNTHIA M. HARDMAN
Decision Date
12 June 2024

Detailed Summary

ResMed Corp. challenged U.S. Patent No. 11690512 owned by Cleveland Medical Devices, Inc. in an IPR proceeding based solely on obviousness (35 U.S.C. § 103). The Board analyzed the discretionary denial factors under Fintiv and determined that while the merits were neutral, Petitioner sufficiently demonstrated a reasonable likelihood of prevailing on Ground 1. Consequently, the Board granted institution, allowing ResMed to proceed with its challenge against claims 1-20 in the healthcare/sleep diagnostics technology space.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in ResMed Corp. vs Cleveland Medical Devices, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call